within Pharmacolibrary.Drugs.ATC.C;

model C01CA13
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00021666666666666666,
    adminDuration  = 600,
    adminMass      = 5 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.035,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C01CA13</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Prenalterol is a selective beta-1 adrenoceptor agonist that was investigated primarily for use in the treatment of heart failure and certain cardiac conditions. It is not widely approved or used today and is mainly of historical or limited investigational interest.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for a healthy adult individual, based on limited non-human and early-phase human data, as no direct, modern human pharmacokinetic studies are published.</p><h4>References</h4><ol><li><p>Clarke, AF, et al., &amp; Smith, SR (1986). The pharmacokinetics of oral and intravenous prenalterol in young, healthy volunteers. <i>Biopharmaceutics &amp; drug disposition</i> 7(1) 47–52. DOI:<a href=\"https://doi.org/10.1002/bdd.2510070107\">10.1002/bdd.2510070107</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3955199/\">https://pubmed.ncbi.nlm.nih.gov/3955199</a></p></li><li><p>Jennings, G, et al., &amp; Korner, P (1983). Cardioselectivity of prenalterol and isoproterenol. <i>Clinical pharmacology and therapeutics</i> 34(6) 749–757. DOI:<a href=\"https://doi.org/10.1038/clpt.1983.245\">10.1038/clpt.1983.245</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6641090/\">https://pubmed.ncbi.nlm.nih.gov/6641090</a></p></li><li><p>Rönn, O (1982). Pharmacokinetics of prenalterol in healthy subjects and patients with congestive heart failure. <i>Acta medica Scandinavica. Supplementum</i> 659 89–98. DOI:<a href=\"https://doi.org/10.1111/j.0954-6820.1982.tb00838.x\">10.1111/j.0954-6820.1982.tb00838.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6127901/\">https://pubmed.ncbi.nlm.nih.gov/6127901</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C01CA13;
